AFP and neoplasm: Node 1, which is characterized by preserved liver function (CP score 5) plus extremely low AFP levels (<5 ng/mL), and node 2, which is characterized by preserved liver function (CP score 5) plus small tumor (size <2.5 cm), showed similar survival to LT, whereas node 3, characterized by preserved liver function (CP score 5) but AFP ≥5 ng/mL and tumor size ≥2.5 cm), showed a lower survival rate than LT, indicating that LT is the best option for node 3, whereas locoregional therapies may be preferable in patients in nodes 1 and 2.